Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype
Lindsay M. Morton(National Cancer Institute), Joseph F. Fraumeni(National Institutes of Health), Neil E. Caporaso(Unknown), Elizabeth C. Bluhm(MedStar Health), Rochelle E. Curtis(National Institutes of Health), Martha S. Linet(National Institutes of Health), Margaret A. Tucker(National Cancer Institute), Lynn A. G. Ries(National Cancer Institute)
Cited by 202
Related Papers
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Replicating genotype–phenotype associations
|Nature|2007|1.4k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k